Medication info
Vytorin 10/40

Vytorin 10/40

Prescription medicationTabletOral
Ingredient · strength
Simvastatin›40mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Organon Korea Co., Ltd.
Appearance
A capsule-shaped tablet, white to off-white, with '313' engraved on one side.
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 200511264 · Approved 2005.01.31 · Insurance code 073100230

Summary

Main use
Improvement of hypercholesterolemia (primary or homozygous familial) and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range of this medicine is 10/10mg to 10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require less LDL cholesterol reduction may start at 10/10mg once daily. After starting treatment with this medicine or adjusting the dose, check blood lipid levels and adjust the dose at intervals of at least 4 weeks. Due to the increased risk of myopathy, including rhabdomyolysis, especially during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have been taking 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration in patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function, under Precautions for Use). Administration in patients with renal impairment and patients with chronic kidney disease No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. If higher doses are administered to these patients, use caution and monitor them carefully (see 5. General Precautions under Precautions for Use). Administration in elderly patients No dose adjustment is required in elderly patients. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Ingredients

Importer
Organon Korea Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary or homozygous familial) and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular diseases due to hypercholesterolemia.
View approved original text

This medication is used as an adjunct to diet for reducing elevated total cholesterol, LDL cholesterol, Apo B, and triglycerides, and for increasing HDL cholesterol in patients with primary hypercholesterolemia (familial and non-familial) and mixed hyperlipidemia. Additionally, it may be administered as an adjunct or alternative therapy in patients with homozygous familial hypercholesterolemia. This medication is to be used in conjunction with a diet that is limited in saturated fat and cholesterol, and should be administered when there is insufficient response to non-drug therapies. Before treatment, it is essential to identify and address secondary causes of dyslipidemia such as diabetes and hypothyroidism. Regular assessments of lipid levels should be conducted to confirm therapeutic efficacy, and this medication may also be considered for patients with acute coronary events. This medication helps to reduce the risks associated with hypercholesterolemia and improve serum lipid levels.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range of this medicine is 10/10mg to 10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require less LDL cholesterol reduction may start at 10/10mg once daily. After starting treatment with this medicine or adjusting the dose, check blood lipid levels and adjust the dose at intervals of at least 4 weeks. Due to the increased risk of myopathy, including rhabdomyolysis, especially during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have been taking 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration in patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function, under Precautions for Use). Administration in patients with renal impairment and patients with chronic kidney disease No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. If higher doses are administered to these patients, use caution and monitor them carefully (see 5. General Precautions under Precautions for Use). Administration in elderly patients No dose adjustment is required in elderly patients. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Precautions

This medication may cause muscle disorders, including myopathy or serious muscle damage, such as rhabdomyolysis. Such muscle issues may occur more frequently with higher doses of simvastatin, which is one of the components of this drug, so caution is required. Particularly, patients taking 80 mg are at a higher risk for muscle-related adverse effects and should consider dose adjustments or alternative therapies if there are drug interactions. This medication should not be used in patients with allergies to its components, patients with severe liver dysfunction, or women who are pregnant or breastfeeding. Patients with impaired liver function should undergo liver function tests before and during treatment. As this medication is metabolized in the liver, it may impose a burden on the liver, potentially elevating liver enzyme levels. Patients with a history of liver disease or liver dysfunction should exercise extra caution while taking this medication. This medication may interact with many other drugs, and the risk of muscle damage may increase when taken with specific antifungals, antibiotics, antivirals, immunosuppressants, certain cardiac medications, niacin, and some other drugs. Therefore, when starting a new medication, patients must inform their physician or pharmacist that they are taking this drug. While taking this medication, if unexplained muscle pain, weakness, or tenderness occurs, immediate medical consultation is required, and treatment should be discontinued if necessary. Women planning to become pregnant or who may become pregnant should not take this medication, and if pregnancy occurs during treatment, it should be discontinued immediately. Additionally, effective contraceptive measures should be employed during treatment. There is insufficient safety data for children and adolescents, so it is not recommended for children under 10 years of age or prepubescent girls. Generally considered safe for older adults, although some older patients may be more sensitive to the drug, necessitating careful monitoring. This medication may slightly elevate blood sugar levels, so patients at high risk for diabetes are advised to regularly monitor their blood glucose levels. In case of overdose, there is no specific antidote, and symptomatic treatment will be provided based on symptoms. Regular blood tests to monitor liver function and muscle enzyme levels during treatment are important for safe therapy.

Side effects

  • Headache
  • diarrhea
  • influenza
  • upper respiratory tract infection
  • myalgia
  • limb pain
  • fatigue
  • abdominal pain
  • viral infection
  • pharyngitis
Show 102 more
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • anaphylaxis
  • urticaria
  • rash
  • angioedema
  • elevated creatine phosphokinase
  • myopathy
  • rhabdomyolysis
  • elevated liver aminotransferase levels
  • hepatitis
  • thrombocytopenia
  • nausea
  • pancreatitis
  • dizziness
  • paresthesia
  • depression
  • cholelithiasis
  • cholecystitis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • eosinophilia
  • drug reaction with systemic symptoms
  • polymorphic erythema
  • weakness
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • pruritus
  • rash
  • muscle cramps
  • specific cranial nerve dysfunction
  • taste disturbance
  • ocular movement disorders
  • facial paresis
  • tremor
  • peripheral neuropathy
  • peripheral nerve palsy
  • mental disorders
  • anxiety
  • sleep disturbances
  • insomnia
  • nightmares
  • cognitive impairment
  • interstitial lung disease
  • angioedema
  • lupus erythematosus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • cholestatic jaundice
  • hepatic steatosis
  • cirrhosis
  • acute liver failure
  • liver cancer
  • alopecia
  • various skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • ocular muscle palsy
  • anemia
  • elevated aminotransferases
  • increased ALP
  • increased gamma-GT
  • elevated bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • abnormal liver function tests
  • increased HbA1c
  • elevated fasting blood sugar levels
  • edema
  • thirst
  • facial swelling
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucous stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a tightly closed container. It is advisable to maintain storage temperatures between 1 degree and 30 degrees Celsius at room temperature. This helps to ensure that the efficacy of the drug is preserved and its quality remains intact.

Appearance and packaging

Appearance

A capsule-shaped tablet, white to off-white, with '313' engraved on one side.

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.